関連する実験動画
Updated: Oct 20, 2025

09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
15.6K
セロトニンの増加は,中毒の強迫を防ぐ
Katsuhiko Miyazaki1, Kayoko W Miyazaki1
1Neural Computation Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan.
まとめ
細胞外セロトニンは重要な神経伝達物質で ネズミのコカイン摂取量を減らすことが判明しました これはセロトニンが 依存性の行動に 作用する可能性があることを示唆しています
科学分野:
- 神経科学
- 薬理学について
- 依存症 研究
背景:
- セロトニンは 気分や報酬など 様々な脳の機能に 関わる神経伝達物質です
- コカイン依存症は依然として深刻な公衆衛生問題であり,有効な治療法は限られている.
研究 の 目的:
- コカイン探求行動に対する細胞外セロトニンの影響を 臨床前モデルで調査する.
- 薬物中毒治療のセロトニン経路の調整の可能性を探るため
主な方法:
- 細胞外セロトニン濃度を変化させる物質をマウスに投与した.
- コカインの自己投与行動が測定されました.
- セロトニン操作に関連した行動反応を分析した.
主要な成果:
- 細胞外セロトニンの増加は,マウスのコカイン摂取量を大幅に減少させた.
- セロトニンのレベルが高くなり,コカインの摂取量が減少した.
結論:
- 細胞外セロトニンは コカインの摂取を制御する上で 重要な役割を果たします
- セロトニン系を標的とした治療は コカイン使用障害の新たな治療策となるかもしれません
関連する概念動画
Drug Dependence
1.3K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
457
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
457
Drug Abuse and Addiction: Pharmacological Phenomena
814
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
814
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
779
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
779
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
505
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
505
Antidepressant Drugs: Overview
913
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
913

